Colgate-Palmolive (CL) Shares Sold by Buckingham Capital Management Inc.

Share on StockTwits

Buckingham Capital Management Inc. cut its holdings in shares of Colgate-Palmolive (NYSE:CL) by 2.3% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 34,718 shares of the company’s stock after selling 819 shares during the period. Buckingham Capital Management Inc.’s holdings in Colgate-Palmolive were worth $2,324,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Victory Capital Management Inc. lifted its stake in shares of Colgate-Palmolive by 9.8% in the 2nd quarter. Victory Capital Management Inc. now owns 90,142 shares of the company’s stock worth $5,842,000 after acquiring an additional 8,046 shares during the period. Segall Bryant & Hamill LLC lifted its stake in shares of Colgate-Palmolive by 47.5% in the 2nd quarter. Segall Bryant & Hamill LLC now owns 24,125 shares of the company’s stock worth $1,564,000 after acquiring an additional 7,771 shares during the period. Tredje AP fonden lifted its stake in shares of Colgate-Palmolive by 81.7% in the 2nd quarter. Tredje AP fonden now owns 103,885 shares of the company’s stock worth $6,733,000 after acquiring an additional 46,703 shares during the period. Swiss National Bank lifted its stake in shares of Colgate-Palmolive by 2.4% in the 2nd quarter. Swiss National Bank now owns 3,245,472 shares of the company’s stock worth $210,339,000 after acquiring an additional 76,000 shares during the period. Finally, Martingale Asset Management L P lifted its stake in shares of Colgate-Palmolive by 16.8% in the 2nd quarter. Martingale Asset Management L P now owns 90,374 shares of the company’s stock worth $5,858,000 after acquiring an additional 13,000 shares during the period. 74.53% of the stock is currently owned by hedge funds and other institutional investors.

CL stock opened at $62.46 on Wednesday. Colgate-Palmolive has a 12 month low of $57.41 and a 12 month high of $77.91. The company has a market cap of $54.57 billion, a P/E ratio of 21.76, a price-to-earnings-growth ratio of 3.09 and a beta of 0.76. The company has a quick ratio of 0.77, a current ratio of 1.11 and a debt-to-equity ratio of 64.85.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, October 26th. The company reported $0.72 EPS for the quarter, meeting the consensus estimate of $0.72. Colgate-Palmolive had a net margin of 13.55% and a return on equity of 12,004.60%. The business had revenue of $3.85 billion during the quarter, compared to analyst estimates of $3.89 billion. During the same period in the prior year, the business earned $0.73 earnings per share. The business’s quarterly revenue was down 3.2% on a year-over-year basis. Equities analysts predict that Colgate-Palmolive will post 2.96 earnings per share for the current fiscal year.

Several analysts recently commented on the stock. Zacks Investment Research lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research note on Monday, October 29th. Wells Fargo & Co cut their target price on shares of Colgate-Palmolive from $64.00 to $62.00 and set a “market perform” rating for the company in a research note on Wednesday, October 17th. Atlantic Securities assumed coverage on shares of Colgate-Palmolive in a research note on Thursday, September 20th. They set a “neutral” rating and a $71.00 target price for the company. SunTrust Banks lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and cut their target price for the company from $80.00 to $65.00 in a research note on Friday, October 26th. Finally, Morgan Stanley cut their target price on shares of Colgate-Palmolive from $65.00 to $60.00 and set a “hold” rating for the company in a research note on Tuesday, October 30th. Two analysts have rated the stock with a sell rating, twelve have assigned a hold rating and two have assigned a buy rating to the stock. Colgate-Palmolive has a consensus rating of “Hold” and a consensus price target of $67.71.

COPYRIGHT VIOLATION NOTICE: “Colgate-Palmolive (CL) Shares Sold by Buckingham Capital Management Inc.” was originally posted by Week Herald and is owned by of Week Herald. If you are accessing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark and copyright law. The legal version of this piece of content can be accessed at https://weekherald.com/2018/12/19/colgate-palmolive-cl-shares-sold-by-buckingham-capital-management-inc.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.

Further Reading: Understanding Average Daily Trade Volume

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply